CLINICAL_TRIALS
research
· 2025-08-29
Clinical Trial Update: Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
Summary
MiMARK Diagnostics is recruiting for a study evaluating a non-invasive in vitro diagnostic test for screening endometrial cancer in high-risk populations.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: MiMARK Diagnostics, S.L. | Conditions: Endometrial Cancer | Status: RECRUITING